VACCINATED DROPPING LIKE FLIES!! IT'S AN EPIDEMIC!
FDA Greenlights Merck’s RSV Shot for Newborns— Clinical Trials Showed 11.71% Rate of Serious Adverse Events, Including Death
The clinical trial results posted on the government website ClinicalTrials(dot)gov included serious neurological adverse reactions that Dr. Peter Selley, a U.K. general practitioner who has closely followed the development of the drugs for RSV, called “concerning.”
These included febrile convulsions, seizures, facial paralysis and brain injury at about three times the rate in the vaccine group (25 of 2,409) as the placebo group (4 of 1,202).Children’s Health Defense Senior Research Scientist Karl Jablonowski said the trials showed a serious adverse event rate of 11.71% and included:
• A 50% greater chance of death (three deaths in the group that received the shot versus one in the placebo group) .• A 350% greater chance of an upper respiratory tract infection .• A 63% greater chance of a lower respiratory tract infection. • A 41% greater chance of febrile convulsion
